SLG
NARI

Stanley-Laman Group’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Stanley-Laman Group’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-38,500
Closed -$3.49M – 314
2022
Q1 		$3.49M Buy
38,500
+6,215
+19% +$509K 0.48% 68
2021
Q4 		$2.95M Buy
+32,285
New +$2.77M 0.35% 92

Other funds holding NARI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Stanley-Laman Group's NARI Position: Q2 2022 in Review

Stanley-Laman Group sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2022, closing a stake of 38,500 shares — an estimated $3.49M sold.

Stanley-Laman Group first reported a position in NARI in Q4 2021 and held it in 2 quarters. The position peaked at $3.49M in Q1 2022. 227 funds tracked by Wall St. Rank hold NARI as of Q2 2022.

  • Stanley-Laman Group reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Stanley-Laman Group sold 38,500 Inari Medical, Inc. Common Stock shares in Q2 2022, an estimated $3.49M.
  • Stanley-Laman Group first reported a position in Inari Medical, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Stanley-Laman Group's Inari Medical, Inc. Common Stock position peaked at $3.49M in Q1 2022.
  • 227 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2022.

Based on Stanley-Laman Group's 13F filing for Q2 2022, filed 8 Aug 2022.